Evli Japan vs UBS Lux Equity Fund Biotech USD

Evli Japan vs UBS Lux Equity Fund Biotech USD

1. Evli Japan

  • Security

    Evli Japan

  • Fee

    1.62%

  • ISIN

    FI0008807722

  • Holdings

    1

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

Fund Holdings

We have information about 2 holdings in Evli Japan, where the largest holding is Inpex (2.05), followed by (0) and (0). In comparison with UBS Lux Equity Fund Biotech USD, we have 7 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66).

All Holdings

Here we compare the holdings in Evli Japan and UBS Lux Equity Fund Biotech USD.

Evli Japan UBS Lux Equity Fund Biotech USD
1. Inpex Corp
Japan
2.05 %
1. Regeneron Pharmaceuticals Inc
10.04 %
- 2. Moderna Inc
9.21 %
- 3. Gilead Sciences Inc
USA
4.66 %
- 4. BioNTech SE
4.13 %
- 5. Karuna Therapeutics Inc
3.75 %

The list of fund holdings was last updated on September 10, 2025.